Navigation Links
Drugs targeting blood vessels may be candidates for treating Alzheimer's
Date:3/7/2013

University of British Columbia researchers have successfully normalized the production of blood vessels in the brain of mice with Alzheimer's disease (AD) by immunizing them with amyloid beta, a protein widely associated with the disease.

While AD is typically characterized by a build-up of plaques in the brain, recent research by the UBC team showed a near doubling of blood vessels in the brain of mice and humans with AD.

The new study, published online last week in Scientific Reports, a Nature journal, shows a reduction of brain capillaries in mice immunized with amyloid beta a phenomenon subsequently corroborated by human clinical data as well as a reduction of plaque build-up.

"The discovery provides further evidence of the role that an overabundance of brain blood vessels plays in AD, as well as the potential efficacy of amyloid beta as basis for an AD vaccine," says lead investigator Wilfred Jefferies, a professor in UBC's Michael Smith Laboratories.

"Now that we know blood vessel growth is a factor in AD, if follows that drugs targeting blood vessels may be good candidates as an AD treatment."

AD accounts for two-thirds of all cases of dementia. The number of Canadians living with dementia is expected to reach 1.4 million by 2013, according to the Alzheimer's Society of Canada.

Jefferies is a researcher in UBC's Michael Smith Laboratories, the Brain Research Centre, and the Centre for Blood Research at UBC. He is also a member of a UBC's departments of Medical Genetics, Microbiology and Immunology, and Zoology. The study was done in collaboration with researchers at UBC's Biomedical Research Centre and Mount Sinai, School of Medicine in New York.


'/>"/>

Contact: Wilfred Jefferies
wilf@msl.ubc.ca
604-827-5167
University of British Columbia
Source:Eurekalert

Page: 1

Related medicine news :

1. Advance in re-engineering photosynthesis to make drugs, compounds or ingredients
2. Wide disparities in access to latest rheumatoid arthritis drugs across Europe
3. Newer Rheumatoid Arthritis Drugs Dont Seem to Increase Risk of Shingles
4. Drugs May Help Relieve Restless Legs Syndrome
5. Researchers show that lipid nanoparticles are ideal for delivering genes and drugs
6. Changing shape makes chemotherapy drugs better at targeting cancer cells
7. Newest Diabetes Drugs Linked to Higher Pancreatitis Risk
8. Report Calls for Better U.S. Efforts to Fight Counterfeit Drugs
9. Emerging cancer drugs may drive bone tumors
10. Countering fake and substandard drugs: IOM report releases Feb. 13
11. Dirty Drugs and We Know It: Attorneys at Console & Hollawell Comment on ISMP Survey Relating to Contaminated Drug Compounds and the Risks to Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... the day, adults often find themselves reaching for a cup of coffee, an energy drink, ... for instead is a cup of Matcha green tea. Matcha is a premium green tea ... harvested from early June to mid-July, when the leaves are the most tender. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... St. ... (Healthconnect) regional health information exchange, which enables physicians at SJMC’s two hospital campuses, ... from other participating organizations in the exchange. SJMC’s membership in the health information ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... DDL, Inc. ... American Association for Laboratory Accreditation (A2LA) to include ISO 594-1 and ISO 594-2 testing ... means of achieving a leak-free connection between two medical devices (e.g. a syringe and ...
(Date:5/31/2016)... ... May 31, 2016 , ... The successful implementation of “lean ... laboratories as well. However, laboratories have different challenges compared to manufacturing environments. , ... in the lab, METTLER TOLEDO has developed the Lean Lab Checklist . This ...
(Date:5/31/2016)... ... May 31, 2016 , ... In his latest ... personality traits in humans. Using presidential candidate Donald Trump as an example, Kalsi ... , “AstroNumerology is not about adding numbers up,” says Kalsi. “It is about ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
Breaking Medicine Technology: